MedPath

The effect of aromatherapy on anxiety and vital signs

Phase 3
Conditions
Anxiety Level.
Anxiety disorder, unspecified
Registration Number
IRCT2012111811515N1
Lead Sponsor
Medical Sciences of Vice chancellor for research, North Khorasan University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
150
Inclusion Criteria

included nulliparous women;
full-term pregnancy (37-42); ages 18-35; with a single fetus; dilatation of3-5 cm ; haven't chronic disease; no colds and haven't nasal congestion; anosmia; lack of sensitivity to smell specific experience of breath smells particular (which bad recalls memories or stress); the use of sedatives or anti-anxiety in 3 hours before the experiment; no known mental illness; no history of epilepsy and asthma; lack of fetal distress; failure to induce labor there was a high risk pregnancy.
Exclusion criteria for the study;
the firm's unwillingness to continue the study of fetal distress or impairment in labor progress during the intervention; use of pain medication during labor induction or intervention

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Anxiety level of first phase of labor. Timepoint: Befor and 20 min after intervention. Method of measurement: Spielberger state-trait.
Secondary Outcome Measures
NameTimeMethod
Pulse rate. Timepoint: Before and 20 minutes after intervention. Method of measurement: examination.;Systolic BP. Timepoint: Before and 20 minutes after intervention. Method of measurement: examination.;Diastolic BP. Timepoint: Before and 20 minutes after intervention. Method of measurement: examination.;Pain intensity. Timepoint: Before and 20 minutes after intervention. Method of measurement: VAS pain scale.
© Copyright 2025. All Rights Reserved by MedPath